Dimensional Fund Advisors
DSGN icon

Dimensional Fund Advisors’s Design Therapeutics DSGN Stock Holding History

Dimensional Fund Advisors’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Buy
694,743
+262,903
+61% +$3.28M ﹤0.01% 2299
2026
Q1 		$4.59M Buy
431,840
+133,919
+45% +$1.36M ﹤0.01% 2522
2025
Q4 		$2.8M Buy
297,921
+18,104
+6% +$142K ﹤0.01% 2667
2025
Q3 		$2.11M Sell
279,817
-33,546
-11% -$168K ﹤0.01% 2754
2025
Q2 		$1.06M Buy
313,363
+24,761
+9% +$92.7K ﹤0.01% 2877
2025
Q1 		$1.11M Buy
288,602
+73,337
+34% +$350K ﹤0.01% 2861
2024
Q4 		$1.33M Buy
215,265
+80,905
+60% +$468K ﹤0.01% 2872
2024
Q3 		$723K Buy
134,360
+53,407
+66% +$251K ﹤0.01% 2964
2024
Q2 		$271K Buy
80,953
+44,098
+120% +$172K ﹤0.01% 3119
2024
Q1 		$149K Sell
36,855
-4,993
-12% -$13.3K ﹤0.01% 3220
2023
Q4 		$111K Sell
41,848
-12,267
-23% -$28.1K ﹤0.01% 3269
2023
Q3 		$128K Sell
54,115
-5,520
-9% -$25.7K ﹤0.01% 3289
2023
Q2 		$375K Sell
59,635
-16,850
-22% -$103K ﹤0.01% 3126
2023
Q1 		$441K Buy
+76,485
New +$572K ﹤0.01% 3056
2022
Q3 		$2.16M Buy
128,872
+100,728
+358% +$2M ﹤0.01% 2696
2022
Q2 		$394K Buy
+28,144
New +$380K ﹤0.01% 3117

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors's DSGN Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Design Therapeutics (DSGN) stake by 61% in Q2 2026, buying an estimated $3.28M and bringing the position to 694,743 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2299.

Dimensional Fund Advisors first reported a position in DSGN in Q2 2022 and has held it in 16 quarters since. 136 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Dimensional Fund Advisors held 694,743 shares of Design Therapeutics worth $10.1M as of Q2 2026.
  • Dimensional Fund Advisors bought 262,903 Design Therapeutics shares in Q2 2026, an estimated $3.28M.
  • Design Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2299 holding.
  • Dimensional Fund Advisors first reported a position in Design Therapeutics in Q2 2022 and has held it in 16 quarters since.
  • 136 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.